- Diagnostics
- Thursday, 09 Jul 2020
CooperRiis Launches New Insurance Driven Intensive Clinical Program
CooperRiis residential mental health treatment and healing community in Western North Carolina is pleased to introduce their new clinically intensive and insurance-driven CooperRiis at Asheville Program, opening September 1st, 2020. The CooperRiis at Asheville Program offers short-term treatment; 30-90 days, designed to promote stabilization and develop a foundation for a potential next step into its longer-term residential program on The CooperRiis Farm in Mill Spring.
The CooperRiis at Asheville Program integrates clinical services through psychiatry, individual and group therapy, and independent skill and functional recovery programming. The recovery program will benefit individuals in early recovery and individuals experiencing setbacks or recurrent mental health and substance use challenges.
The CooperRiis at Asheville Program treats adults 18 and over who experience mental health diagnoses such as anxiety, major depression, PTSD, bipolar disorder, schizophrenia, personality disorders, and any co-occurring condition related to addiction (dual diagnosis).
The CooperRiis at Asheville Program provides clinical services that will include psychotherapy, psychiatry, experiential group therapy, optimized medication use, psychoeducation, and 24-hour nursing. Evidenced-based group modalities are offered, such as Dialectical Behavioral Therapy (DBT), Acceptance and Commitment Therapy (ACT), Expressive Arts Therapy, and Psychosis Support.
The introduction of this new program is especially relevant today, as the COVID-19's emerging impact on society's mental health has been profound. The CooperRiis commitment to the principles of recovery provides an essential service for people whose emotional well-being has been further compromised by the pandemic.
"CooperRiis believes that with its focused attention, this program can help address the emerging societal complexity of the virus epidemic with this vulnerable population," Eric A. Levine, Ed.D, President and CEO.
Related Industry Updates
Animal Health Market to Register Steady Expansion During 2020-2027 BY Merck & Co., Inc. ,BoehringerIngelheim International GmbH ,Ceva Santé Animale ,Cargill, Incorporated
Mar 30, 2021
CVS Health to Significantly Expand COVID-19 Testing Capabilities
Apr 28, 2020
North America Cancer tissue diagnostics market is expected to reach US$ 4,350 million by 2027 with CAGR of 8%.
Oct 20, 2020
Chinese scientists seeking several potential COVID-19 treatment find 'extremely effective' antibodies
Apr 01, 2020
PSA Test Explained: What It Is, How It Works, and Why It Matters
Mar 27, 2026
Sepsis Diagnostics: Early Detection Saves Lives
Feb 17, 2026
Conduent: Disease Surveillance and Outbreak Management System to Fight Coronavirus
Feb 19, 2020